According to Zhitong Financial App, GUANZE MEDICAL (02427) announced its 2023 interim results, with revenue of RMB 74.413 million (same unit), a decrease of 24.5% over the previous year; profit attributable to company owners was 15.948 million yuan, an increase of 4.13% over the previous year; and profit of 0.02 yuan per share.
The announcement stated that the decrease in revenue was mainly due to a decrease in revenue from the sale of medical imaging film products. Sales revenue of medical imaging film products fell by about 26.8% to 67.9 million yuan during the period, mainly due to the gradual shift in customer demand from third-party international brand film to the company's own brand medical film.